跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
密固达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Zoledronic Acid Injection
Approved
化学药品
Zoledronic Acid Injection
Sandoz Pharmaceuticals AG
🇨🇳 National Medical Products Administration
Approval Date
Sep 27, 2022
Approval ID
4b7c86aa9ca52ad3
Company
Sandoz Pharmaceuticals AG
Type
化学药品
Approval Details
Approval Id
4b7c86aa9ca52ad3
Approval Number
国药准字HJ20181132
Generic Name
唑来膦酸注射液
Generic Name En
Zoledronic Acid Injection
Trade Name
密固达
Drug Type
化学药品
Dosage Form
注射剂
Strength
100ml∶5mg(按C₅H₁₀N₂O₇P₂计)
Reg Date
2022-09-27
Expired Date
2027-09-26
Company Name
Sandoz Pharmaceuticals AG
Production Company Name
Fresenius Kabi Austria Gmbh
Company Detail Path
/organization/sandoz-pharmaceuticals-ag
Production Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 27, 2022
Approval ID
4b7c86aa9ca52ad3
Type
化学药品
Back to NMPA Approvals